Trial Radar KI | ||
|---|---|---|
enums.trial_summary.trial_summary_welcome | ||
Eine Studie entspricht den Filterkriterien
Kartenansicht
Zurück zur Suche
MD Anderson KrebszentrumWatchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT03575832 ist eine interventionsstudie zur Untersuchung von Stadium I Prostatakrebs AJCC v8, Stadium II Prostatakrebs AJCC v8, Prostatakrebs im Stadium IIA AJCC v8, Prostatakrebs im Stadium IIB AJCC v8, Prostatakrebs im Stadium IIC AJCC v8, Stadium III Prostatakrebs AJCC v8, Stadium IIIA Prostatakrebs AJCC v8, Stadium IIIB Prostatakrebs AJCC v8, Stadium IIIC Prostatakrebs AJCC v8 und hat den Status aktiv, nicht rekrutierend. Die Studie startete am 25. Januar 2018 und soll 64 Teilnehmer aufnehmen. Durchgeführt von MD Anderson Krebszentrum ist der Abschluss für 31. Dezember 2025 geplant. Die Daten von ClinicalTrials.gov wurden zuletzt am 14. August 2025 aktualisiert.
Kurzbeschreibung
This pilot trial studies how well Watchful Living works in improving quality of life in participants with prostate cancer that has not spread to other parts of the body who are on active surveillance and their partners. A social support lifestyle intervention (called Watchful Living) may help African American prostate cancer participants and their partners improve their quality of life, physical activity, diet, and inflammation.
Ausführliche Beschreibung
PRIMARY OBJECTIVES:
I. To determine the feasibility of recruiting and implementing a lifestyle intervention for prostate cancer patients and their partners.
SECONDARY OBJECTIVES:
I. To evaluate the preliminary efficacy of a lifestyle intervention in improving diet, physical activity, physical fitness, partner's support, quality of life, and inflammation at the end of the study (month 6).
II. To conduct a process evaluation of the lifestyle intervention. III. Explore participants' satisfaction, likes/dislikes, strengths, weaknesses, and areas of improvement regarding the program.
OUTLINE:
Participants receive an exercise plan and printed materials at baseline. Participants also receive 10 telephone coaching calls over 45-60 minutes weekly during month 1, every 2 weeks during month 2, and every month during months 3-6. Participants complete 2 nutrition counseling sessions before month 3.
Offizieller Titel
Watchful Living: A Lifestyle Intervention for Black and Hispanic Prostate Cancer Patients and Their Partners
Erkrankungen
Stadium I Prostatakrebs AJCC v8Stadium II Prostatakrebs AJCC v8Prostatakrebs im Stadium IIA AJCC v8Prostatakrebs im Stadium IIB AJCC v8Prostatakrebs im Stadium IIC AJCC v8Stadium III Prostatakrebs AJCC v8Stadium IIIA Prostatakrebs AJCC v8Stadium IIIB Prostatakrebs AJCC v8Stadium IIIC Prostatakrebs AJCC v8Weitere Studien-IDs
- 2017-0556
- NCI-2018-01406 (Registerkennung) (CTRP (Clinical Trial Reporting Program))
- 2017-0556 (Andere Kennung) (M D Anderson Cancer Center)
NCT-Nummer
Studienbeginn (tatsächlich)
2018-01-25
Zuletzt aktualisiert
2025-08-14
Studienende (vorauss.)
2025-12-31
Geplante Rekrutierung
64
Studientyp
Interventionsstudie
PHASE
Nicht zutreffend
Status
Aktiv, nicht rekrutierend
Primäres Ziel
Prävention
Zuteilungsmethode
Nicht zutreffend
Interventionsmodell
Einarmige Studie
Verblindung
Keine (offene Studie)
Studienarme/Interventionen
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
ExperimentellSupportive care (exercise, nutrition counseling) Participants receive an exercise plan and printed materials at baseline. Participants also receive 10 telephone coaching calls over 45-60 minutes weekly during month 1, every 2 weeks during month 2, and every month during months 3-6. Participants complete 2 nutrition counseling sessions before month 3. | Beratung Complete nutrition counseling sessions Informationsintervention Receive an exercise plan and printed materials Lebensqualitätsbewertung Ancillary studies Fragebogenverwaltung Ancillary studies Telefonbasierte Intervention Receive telephone coaching calls |
Hauptergebnismessungen
Nebenergebnismessungen
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Recruitment and retention | Rates of study eligibility, recruitment, and retention will be assessed. Will maintain detailed information during the recruitment process regarding numbers of patients and their partners interested, eligible, ineligible (and reasons for ineligibility), and enrolled (and reasons for choosing not to enroll if deemed eligible). Will calculate rates of study eligibility, recruitment, and retention, along with 90% confidence intervals (CIs). Participant feedback will be summarized using means and standard deviations (SDs), along with graphical display (e.g., box plots). Will also assess reasons for withdrawal from study among those that chose to withdraw. Will examine the differences between dropout and non-dropout group at each time point by demographic factors such as age, gender, marital status, education, and income. | Up to 8 months |
Intervention adherence | The intervention adherence rate for each dyad is defined as the proportion of intervention sessions completed by both the patient and partner. Will also look at percentage of both patient and partner completing a minimum of 7 out of 10 coaching calls and both nutrition counseling sessions. | Up to 8 months |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Surveillance lifestyle | Will report means, standard deviations, and distributions of survey measures (including pre-post changes of these measures, as appropriate) for ceiling/floor effects and restrictions in range. Outcome measures will be treated as continuous variables. Linear mixed models will be used when combined data from both patients and partners are analyzed due to their correlation within couples. Two-sided statistical tests will be performed, and the significance level for each test will be set at 0.05 without adjustment for multiple testing. All results from the statistical tests will be interpreted as hypothesis generating rather than conclusive findings. Will also perform paired t-tests to compare efficacy outcomes of interest between baseline and post intervention separately for patients and partners. | Up to 8 months |
Elements of the intervention that were successful and/or need improvements | Will conduct focus groups with a subsample of patient-partner dyads. Questions will address participants' experiences; thoughts about strengths, weaknesses, and needed improvements; perceptions about outcomes and impact; and overall reactions to and satisfaction with the intervention. | Up to 8 months |
Eignungskriterien
Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
Akzeptiert gesunde Freiwillige
Ja
- Self-identify as black or African American or Hispanic (patient)
- Be greater than 18 years of age (patient and spouse or intimate partner)
- Have 0-III stage prostate cancer (patient)
- If treated, have completed therapy (e.g., surgery, chemo and/or radiation) (patient)
- Enroll with a spouse or intimate partner (patient)
- Do not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week) (patient and spouse or intimate partner)
- Be ready and able to be physically active, as determined by a physician (letter from a physician or nurse practitioner) (patient and spouse or intimate partner)
- Not participate in another physical activity, diet, or lifestyle program (patient)
- Have a valid home address and telephone number (patient)
- Internet access at home or other location (e.g., work, church, library, community center, etc.) (spouse or intimate partner)
- Patients on active surveillance will be included
- They have an active noncutaneous malignancy at any site (patient)
- Had prior radiation therapy for treatment of the primary tumor (patient)
- Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period (patient)
- Are enrolled in another active surveillance protocol (patient)
- Participated in formative focus groups for this study (patient and spouse or intimate partner)
MD Anderson Krebszentrum1128 aktive klinische Studien zum ErkundenNationales Krebsinstitut, USA3028 aktive klinische Studien zum ErkundenKeine Kontaktdaten vorhanden
2 Studienstandorte in 1 Ländern
Texas
Harris Health System (LBJ), Houston, Texas, 77026, United States
M D Anderson Cancer Center, Houston, Texas, 77030, United States